Synta Pharmaceuticals Corp $3.89

down -0.06


15/9/2014 04:00 PM  |  NASDAQ : SNTA  
Industries : Drugs / Biotechnology
Get Trend Analysis Icon Get SNTA Trend Analysis - it has underperformed the S&P 500 by 60%

Partner Headlines

  1. InterMune's Roche Deal Sends Peer Group Up

    Benzinga
  2. Synta Announces Advancement Of Ganetespib Into Phase 3 Extension Of AML ...

    Benzinga
  3. Events Scheduled for Week of Jun 23rd to Jun 27th, 2014

    Benzinga
  4. 5-Star Biotech Stock Watch: Synta Pharmaceuticals

    Benzinga
  5. 3 Biotech Stocks Backed By Big Money

    Benzinga
  6. Morning Market Movers

    Benzinga
  7. Benzinga's Top #PreMarket Gainers

    Benzinga
  8. Top Trending Tickers On StockTwits For March 12

    Benzinga
  9. Morning Movers for March 12th, 2014

    Benzinga
  10. Morning Market Losers

    Benzinga
  11. Benzinga's Top #PreMarket Losers

    Benzinga
  12. UPDATE: Stifel Downgrades Synta Pharmaceuticals as GALAXY-2 Adjustments ...

    Benzinga
  13. Earnings Scheduled For March 11, 2014

    Benzinga
  14. Stocks Hitting 52-Week Lows

    Benzinga
  15. Synta Pharmaceuticals Announces Proposed Public Offering of Common Stock ...

    Benzinga
  16. Synta Presents Positive One-Year Follow-up Results for GALAXY-1 Trial of ...

    Benzinga
  17. Synta Announces Encouraging Results of Ganetespib GALAXY-1 Trial at ECC ...

    Benzinga
  18. Shares of Synta Moving Higher Following News of Fast Track Designation ...

    Benzinga
  19. These Three Speculative Companies Are Loved By Insiders and Institutions

    Benzinga
  20. Synta Provides Clinical Updates

    Benzinga
  21. Synta Provides Clinical Updates

    Benzinga
  22. Market Wrap for Monday, July 29: Stocks Record Moderate Losses to Start ...

    Benzinga
  23. Synta Pharmaceuticals Surges 45% on Positive ENCHANT-1 Breast Cancer Results

    Benzinga
  24. Synta Announces ENCHANT-1 Breast Cancer Results Support Transition to Second ...

    Benzinga
  25. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus
  26. Synta Pharmaceuticals, Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus
  27. Synta Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  28. UPDATE: Jefferies Raises PT to $22 on Synta Pharmaceuticals on GALAXY Update

    Benzinga
  29. UPDATE: Stifel Nicolaus Initiates Synta Pharmaceuticals at Hold; Enthusiasm ...

    Benzinga
  30. Synta Announces $25.8 Million Registered Direct Offering of Common Stock

    Benzinga
  31. Weekly CEO Buys Highlight: SNTA, MEI, PZG, MCHX, CMXI

    GuruFocus
  32. Synta Pharmaceuticals Inc. (SNTA) CEO Safi R Bahcall buys 10,000 Shares

    GuruFocus
  33. Health Care Sector Wrap

    FoxBusiness
  34. Synta Pharmaceuticals (SNTA) Up 15% after Jefferies Issues Bullish Note

    MarketIntelligenceCenter
  35. UPDATE: Jefferies Raises PT on Synta from $7 to $14

    Benzinga
  36. Teva Pharmaceutical Industries, Constellation Brands Among Stocks Up on ...

    FoxBusiness
  37. Quest Software, Pharmacyclics, Other Stocks Hit 52-Week Highs Monday

    FoxBusiness
  38. Merck &, Onyx Pharmaceuticals Among Stocks Hitting 52-Week Highs Friday

    FoxBusiness
  39. UPDATE: BMO Capital Markets Upgrades Synta Pharmaceuticals to Outperform ...

    Benzinga
  40. Benzinga's Top Pre-Market Losers

    Benzinga
  41. Today's Top Small-Cap Winners!

    Benzinga
  42. UPDATE: Jefferies Initiates Coverage on Synta Pharmaceuticals

    Benzinga
  43. Synta Pharmaceuticals Inc. Reports Operating Results (10-K)

    GuruFocus
  44. Earnings Scheduled For February 22

    Benzinga
  45. These 4 Biotech Stocks Are a Buy Now

    GuruFocus
  46. Notable Put Options Activity in Synta Pharmaceuticals

    Benzinga
  47. UPDATE: Synta Prices 7M Shares at $4.40 Each

    Benzinga
  48. McNicoll Lewis & Vlak Reiterates Buy, $10 Target on Synta Pharmaceuticals

    Benzinga
Trading Center